Introducing Biomaterials and Biosystems Elsevier is delighted to announce the launch of its newest title in the biomaterials science portfolio: Biomaterials and Biosystems. The journal sits alongside Biomaterials, Materials Today Bio, Acta Biomaterialia and Materials Science and Engineering C: Materials for Biological Applications. As part of the broader Materials Today family, Biomaterials and Biosystems offers authors rigorous peer review, rapid decisions, and high visibility. Biomaterials and Biosystems is an interdisciplinary open access journal that publishes work at the nexus of engineering, chemistry, biology and medicine. The Journal covers the full spectrum of research, technology development and clinical translation of the biomedical engineering discipline. The Journal will effectively disseminate new knowledge, technologies, tools and discoveries in the field of human health and/or healthcare to the scientific community and to the wider community. The Journal commits to adhere to strict confidentiality agreements and affirms commitment to integrity and ethical conduct of the highest standard. The Journal is led by Editor in Chief, Professor Dimitrios Zeugolis. Dimitrios I. Zeugolis is the Director of the Regenerative, Modular & Developmental Engineering Laboratory (REMODEL) at National University of Ireland Galway, Ireland. Dimitrios is President-elect of Matrix Biology Ireland and Editorial Committee member-elect of the Tissue Engineering and Regenerative Medicine International Society. Dimitrios has authored over 100 peer-reviewed articles, 400 peer-reviewed conference papers and 15 peer-reviewed book chapters. He is on the editorial board of 10 journals and acts as reviewer for 130 journals and 30 funding agencies. Dimitrios has chaired / co-chaired 15 conferences and 50 symposia and has acted as advisor in 25 conferences. Dimitrios has secured 2 patents and founded 2 companies. He has conducted research for over 40 companies and has been involved in the development and commercialisation of numerous food and medical device products. All submissions through 2020 and 2021 are waived, so please do consider submitting your work to the journal! Find out more .